"Like the previous year, poor and minority teen girls who start the three-dose HPV series have lower rates of finishing it. Coverage was also lower for younger girls, meaning 11- and 12-year-olds are not getting the vaccine as recommended," according to a CDC news release. Giving the HP...
Since it was licensed, CDC and FDA have been closely monitoring the safety of the HPV vaccine. There are 3 systems used to monitor the safety of vaccines after
Pause and think about the conflicting information that has been coming out from WHO with regards to the current virus.Well done Italy!FIVE NWO approved science scammers are protesting a vaccine safety investigation being conducted by Italy’s real top scientists who are rapidly and easily ...
(HealthDay)—The number of cervical precancers (CIN2+ cases) in the United States declined from 2008 to 2016, likely in part because of prevention with the human papillomavirus (HPV) vaccine, according to research published in the April 19 issue of the U
The vaccine, which was developed by Merck & Co., is highly effective against four types of human papillomavirus, two of which can cause cervical cancer. A vaccination series that would be given to girls aged 11 to...
The rationale behind the recommendation is that the vaccine prevents genital warts and anal cancers in males, both of which can be caused by HPV
But, the coverage rate for the HPV vaccine still lags substantially behind that of the meningitis vaccine, and it's not equal in all areas of the country. Stokley explains that while Rhode Island has the highest coverage rate for the first dose among girls (76%), Kansas has the lowest (...
The rationale behind the recommendation is that the vaccine prevents genital warts andanal cancersin males, both of which can be caused by HPV. The vaccine may also prevent head and neck cancer, which has been on the rise in recent years. ...
[4] HPV (Human Papillomavirus) Vaccine: What You Need to Know. retrieved October 30, 2019, from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fhcp%2Fvis%2Fvis-statements%2Fhpv-gardasil.html ...
“Today’s decision from ACIP emphasizeswhat the data has shown– that the HPV vaccine is safe and effective for use in patients ages 27 to 45, and that use of the vaccine in this age group should be the result of shared decision-making between patients and their trusted physicians,” Zah...